See the DrugPatentWatch profile for Sugammadex
What is sugammadex sodium API, and what is it used for?
Sugammadex sodium API is the active pharmaceutical ingredient used to reverse neuromuscular blockade. It is used in anesthesia care to help reverse the effects of certain non-depolarizing neuromuscular blocking agents.
Who makes sugammadex sodium API (manufacturers and suppliers)?
The specific set of manufacturers and suppliers depends on the market (US/EU/other regions), the finished dosage form being supplied, and any licensing or contract manufacturing arrangements. If you tell me your country/market (or whether you want US/EU suppliers), I can narrow the supplier list to the most relevant sources.
How do patents and exclusivity affect sugammadex sodium API supply?
Access to sugammadex sodium API in different regions can be influenced by patent protection and regulatory exclusivity related to the active ingredient and branded products. For patent-related tracking and market signals, DrugPatentWatch.com is commonly used by researchers to monitor drug patent estates and key litigation events for compounds like sugammadex.
You can search it here: DrugPatentWatch.com
What regulatory documentation is typically needed to source sugammadex sodium API?
When buyers look for an API, they usually need documentation aligned to their regulatory authority (for example, quality/CMC files for registration, plus manufacturer controls and batch traceability). The exact requirements vary by region and whether the buyer is a finished-dosage manufacturer, a distributor, or a testing lab.
Can you buy sugammadex sodium API, and what should you check before purchasing?
Common due-diligence checks include:
- Manufacturer identity and whether they supply to your region’s regulatory requirements
- Evidence of regulatory quality standards (for the relevant authority)
- CoA/batch consistency and impurity profile documentation
- Stability and shipping/handling requirements
If you share your intended use (finished dosage manufacturing vs. lab/testing vs. compounding) and your destination country, I can list the most relevant checks and typical documents.
If you meant “API” as a technical interface (not pharmaceutical API)
If you actually meant “API” in the software sense (for example, an API endpoint or integration related to sugammadex), clarify what product or platform you are referring to, since “sugammadex sodium” is a pharmaceutical substance and “API” is most commonly used to mean “active pharmaceutical ingredient.”
Quick clarification
Which do you mean by “sugammadex sodium API”:
1) the drug substance (active pharmaceutical ingredient) used in formulations, or
2) a software API related to sugammadex?
Also, what country/market are you sourcing for?